Form D · Pharmaceuticals

Oligomerix, Inc.

White Plains, NY · CIK 0001543843

Offering snapshot reported Dec 6, 2024 · SEC filing

Reported sold
$75K
Offering amount: $650K
Investors reported
3
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Nov 25, 2024
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 6, 2024Initial$75,000No comparison3SEC filing
Mar 29, 2022Initial$2,440,568No comparison12SEC filing
Apr 15, 2015Initial$400,000No comparison2SEC filing
Feb 14, 2013InitialYet to sellNo comparison0SEC filing
Mar 20, 2012InitialYet to sellNo comparison0SEC filing

Offering details

Securities
Debt
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-531375

Source: Form D, filed Dec 6, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Jeffrey Bluestein Director
David Dantzker Director
Eliot Davidowitz Director, Executive
Douglas Durand Director
William Erhardt Director, Executive
Robert Foerster Director, Executive
Robert Forester Executive
Victor Micati Director
James Moe Director, Executive
Jack Pasini Director, Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
2 Westchester Park Drive Suite 208
White Plains, NY, 10604